Ann Clin Microbiol.  2020 Mar;23(2):67-72. 10.5145/ACM.2020.23.2.3.

Comparison of Three Methods with CHROMagar for Surveillance Culture of Carbapenem-Resistant Acinetobacter baumannii

• Jeon K
• Lee SS
• Kim HS
• Kim JS
• Lee YK
• Song W
• Kim HS

• KMID: 2506544
• DOI: http://doi.org/10.5145/ACM.2020.23.2.3

Abstract

Background
Carbapenem-resistant Acinetobacter baumannii (CRAB) has emerged as an important nosocomial pathogen.The purpose of this study was to determine the effective methods for performing surveillance cultures of CRAB.
Methods
Nasal and rectal swabs were obtained concurrently from hospitalized intensive care unit patients colonized with CRAB. All the samples were inoculated in CHROMagar Acinetobacter medium with CR102 (CHROMagar), MacConkey agar medium supplemented with 5 µg/mL imipenem (MCA-IPM), and triptic soy broth medium supplemented with 5 µg/ mL imipenem (TSB-IPM). CRAB detection rates for each sample were compared.
Results
The CRAB detection rate in either one of the nasal or rectal swabs from the 37 patients tested were 89.2% (33/37) with the use of CHROMagar, 78.4% (29/37) with the use of MCA-IMP, and 86.5% (32/37) with the use of TSB-IMP.
Conclusion
We determined that concurrent use of both nasal and rectal swabs and CHROMagar could be an effective method for CRAB surveillance cultures.

Keyword

Acinetobacter baumannii; CHROMagar Acinetobacter; Surveillance culture

Reference

1. Gilad J and Carmeli Y. Treatment options for multidrug-resistant Acinetobacter species. Drugs 2008;68:165-89.

2. Agusti C, Pujol M, Argerich MJ, Ayats J, Badia M, Dominguez A, et al. Short-term effect of the application of selective decontamination of the digestive tract on different body site reservoir ICU patients colonized by multi-resistant Acinetobacter baumannii. J Antimicrob Chemother 2001;49:205-8.

3. Heritier C, Dobouix A, Poirel L, Marty N, Nordmann P. A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA58. J Antimicrob Chemother 2005;55:115-8.

4. Marchaim D, Navon-Venezia S, Schwartz D, Tarabeia J, Fefer I, Schwaber MJ, et al. Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii. J Clin Microbiol 2007;45:1551-5.

5. Maragakis LL and Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment option. Clin Infect Dis 2008;15:1254-63.

6. Doi Y, Onuoha EO, Adams-Haduch JM, Pakstis DL, McGaha TL, Werner CA, et al. Screening for Acinetobacter baumannii colonization by use of sponges. J Clin Microbiol 2011;49:154-8.

7. Gordon NC and Wareham DW. Evaluation of CHROMagar Acinetobacter for detection of enteric carriage of multidrug-resistant Acinetobacter baumannii in samples from critically ill patients. J Clin Microbiol 2009;47:2249-51.

8. Fournier PE and Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 2006;42:692-9.

9. Ayats J, Corbella X, Ardanuy C, Dominguez MA, Ricart A, Ariza J, et al. Epidemiological significance of cutaneous, pharyngeal, and digestive tract colonization by multiresistant Acinetobacter baumannii in ICU patients. J Hosp Infect 1997;37:287-95.

10. Lortholary O, Fago JY, Hoi AB, Mahieu G, Gutmann L. Colonization by Acinetobacter baumannii in intensive-care-unit patients. Infect Cont Hosp Epidemiol 1998;19:188-90.

11. Song W, Lee J, Kim TK, Park MJ, Kim HS, Kim JS. Modified CHROMagar Acinetobacter medium for direct detection of multidrug-resistant Acinetobacter strains in nasal and rectal swab samples. Ann Lab Med 2013;33:193-5.

12. Moran-Gilad J, Adler A, Schwartz D, Navon-Venezia S, Carmeli Y. Laboratory evaluation of different agar media for isolation of carbapenem-resistant Acinetobacter spp. Eur J Clin Microbiol Infect Dis 2014;33:1909-13.

13. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; 28th informational supplement. M100-S28. Wayne; PA: 2018.